Cargando…

Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma

BACKGROUND: Herein, we investigate the relationship between pancreatic stem cell markers (PCSC markers), CD44, and epithelial-specific antigen (ESA), tumor stroma, and the impact on recurrence outcomes in pancreatic ductal adenocarcinoma (PDAC) patients. METHODS: PDAC patients who underwent surgical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Askan, Gokce, Sahin, Ibrahim Halil., Chou, Joanne F., Yavas, Aslihan, Capanu, Marinela, Iacobuzio-Donahue, Christine A., Basturk, Olca, O’Reilly, Eileen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034174/ https://www.ncbi.nlm.nih.gov/pubmed/33836674 http://dx.doi.org/10.1186/s12885-021-08123-w

Ejemplares similares

Expression of Calretinin, Marker of Mesothelial Differentiation, in Pancreatic Ductal Adenocarcinoma: A Potential Diagnostic Pitfall
por: Askan, Gokce, et al.
Publicado: (2021)

Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma
por: Hayashi, Akimasa, et al.
Publicado: (2020)

DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma
por: Vyas, Monika, et al.
Publicado: (2019)

Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior
por: Sahin, Ibrahim H., et al.
Publicado: (2018)

Mesenchymal Tumors Involving the Pancreas: A Clinicopathologic Analysis and Review of the Literature
por: Askan, Gokce, et al.
Publicado: (2022)

Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes
por: Gu, Lilly, et al.
Publicado: (2022)

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
por: Moffitt, Richard A., et al.
Publicado: (2015)

Comparative Characterization of Stroma Cells and Ductal Epithelium in Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
por: Helm, Ole, et al.
Publicado: (2014)

Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2018)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
por: Wang, Lai Mun, et al.
Publicado: (2015)

Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022)

Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma
por: Zheng-Lin, Binbin, et al.
Publicado: (2022)

Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
por: Gebauer, Florian, et al.
Publicado: (2017)

Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma
por: Di Maggio, Francesco, et al.
Publicado: (2016)

Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study
por: Singh, Ritu R., et al.
Publicado: (2022)

Induction and characterization of pancreatic cancer in a transgenic pig model
por: Boas, F. Edward, et al.
Publicado: (2020)

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2019)

Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
por: Liot, Sophie, et al.
Publicado: (2021)

An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course
por: Kohutek, Zachary A., et al.
Publicado: (2017)

3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenocarcinoma
por: Liu, Xinyuan, et al.
Publicado: (2021)

Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes
por: O'Reilly, Eileen M., et al.
Publicado: (2020)

Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma
por: Liu, Dajia, et al.
Publicado: (2020)

The tumor–stroma ratio and the immune microenvironment improve the prognostic prediction of pancreatic ductal adenocarcinoma
por: Lu, Mei, et al.
Publicado: (2023)

Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma
por: Rodić, Nemanja, et al.
Publicado: (2015)

Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma
por: Grbovic-Huezo, Olivera, et al.
Publicado: (2020)

Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2023)

Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma
por: Jiang, Jiahong, et al.
Publicado: (2021)

Tumor Stroma Area and Other Prognostic Factors in Pancreatic Ductal Adenocarcinoma Patients Submitted to Surgery
por: Amaral, Maria João, et al.
Publicado: (2023)

Revisiting stroma in pancreatic cancer
por: Khan, Sheema, et al.
Publicado: (2015)

T cells in pancreatic cancer stroma
por: Goulart, Michelle R, et al.
Publicado: (2021)

Pancreatic cancer, stroma, and exosomes
por: Closa, Daniel
Publicado: (2022)

HMGA1 Correlates with Advanced Tumor Grade and Decreased Survival in Pancreatic Ductal Adenocarcinoma
por: Hristov, Alexandra C., et al.
Publicado: (2009)

High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
por: Huang, Jianfei, et al.
Publicado: (2015)

Diffusion Kurtosis Imaging—A Superior Approach to Assess Tumor–Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Mayer, Philipp, et al.
Publicado: (2020)

Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma
por: Robin, Fabien, et al.
Publicado: (2020)

CT Radiomics and Machine-Learning Models for Predicting Tumor-Stroma Ratio in Patients With Pancreatic Ductal Adenocarcinoma
por: Meng, Yinghao, et al.
Publicado: (2021)

Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma
por: Garcia, Paloma E., et al.
Publicado: (2020)

B cells in pancreatic cancer stroma
por: Delvecchio, Francesca Romana, et al.
Publicado: (2022)

Targeting the Stroma in the Management of Pancreatic Cancer
por: Edwards, Penelope, et al.
Publicado: (2021)

In Silico analyses of host immunity and stroma provide prognostic factors in early stage pancreatic ductal adenocarcinoma (PDAC)
por: Williams, Madison H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a42i97c2p3v7704irdt0h2v7k4